However, the distribution of CD8+ TRM within melanoma tissues, their prognostic value, the specific marker of CD8+ TRM and the mechanisms by which they mediate tumour surveillance and regulate the local microenvironment remain poorly understood. The gene discussed is CD8A; the disease is neoplasm.